• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immune checkpoint inhibitors: Advances and impact in neuro-oncology.

作者信息

Fares Jawad, Fares Mohamad Y, Fares Youssef

机构信息

Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Cancer Biology and Therapeutics: High-Impact Cancer Research Program, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Surg Neurol Int. 2019 Jan 25;10:9. doi: 10.4103/sni.sni_366_18. eCollection 2019.

DOI:10.4103/sni.sni_366_18
PMID:30783540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6367947/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a1/6367947/ee67917d02d6/SNI-10-9-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a1/6367947/ee67917d02d6/SNI-10-9-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a1/6367947/ee67917d02d6/SNI-10-9-g001.jpg

相似文献

1
Immune checkpoint inhibitors: Advances and impact in neuro-oncology.免疫检查点抑制剂：神经肿瘤学的进展与影响
Surg Neurol Int. 2019 Jan 25;10:9. doi: 10.4103/sni.sni_366_18. eCollection 2019.
2
Immune checkpoint inhibitors win the 2018 Nobel Prize.免疫检查点抑制剂荣获 2018 年诺贝尔生理学或医学奖。
Biomed J. 2019 Oct;42(5):299-306. doi: 10.1016/j.bj.2019.09.002. Epub 2019 Nov 5.
3
Development of immune checkpoint therapy for cancer.癌症免疫检查点治疗的发展。
J Exp Med. 2019 Jun 3;216(6):1244-1254. doi: 10.1084/jem.20182395. Epub 2019 May 8.
4
[IMMUNOTHERAPY WITH CHECKPOINT INHIBITORS (ICPI) AND IMMUNE RELATED ADVERSE EVENTS (IRAE'S)].[使用检查点抑制剂的免疫疗法（ICPI）与免疫相关不良事件（IRAE）]
Harefuah. 2020 Jul;159(7):508-515.
5
[From the time in the wilderness to the Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo: the Long March of cancer immunotherapy].[从荒野岁月到詹姆斯·艾利森（James Allison）和本庶佑（Tasuku Honjo）荣获诺贝尔生理学或医学奖：癌症免疫疗法的长征之路]
Med Sci (Paris). 2019 Apr;35(4):367-373. doi: 10.1051/medsci/2019074. Epub 2019 Apr 30.
6
[Cancer immunotherapy crowned with Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo].[癌症免疫疗法荣获诺贝尔生理学或医学奖，授予詹姆斯·艾利森和本庶佑]
Med Sci (Paris). 2019 Apr;35(4):365-366. doi: 10.1051/medsci/2019073. Epub 2019 Apr 30.
7
A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens.一项值得获得诺贝尔奖的追求：癌症免疫学和利用免疫来靶向肿瘤新生抗原。
Immunology. 2018 Nov;155(3):283-284. doi: 10.1111/imm.13008.
8
Nobel committee honors tumor immunologists.诺委会表彰肿瘤免疫学家。
J Exp Clin Cancer Res. 2018 Oct 30;37(1):262. doi: 10.1186/s13046-018-0937-6.
9
Immune checkpoint blockade therapy: the 2014 Tang Prize in Biopharmaceutical Science.免疫检查点阻断疗法：2014 年唐奖生技医药奖。
Biomed J. 2015 Jan-Feb;38(1):5-8. doi: 10.4103/2319-4170.151150.
10
Immunotherapy in breast cancer.乳腺癌的免疫疗法。
J Carcinog. 2019 May 23;18:2. doi: 10.4103/jcar.JCar_2_19. eCollection 2019.

引用本文的文献

1
A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts.散发性克雅氏病的系统评价：发病机制、诊断及治疗尝试
Neurol Int. 2024 Sep 20;16(5):1039-1065. doi: 10.3390/neurolint16050079.
2
Updates and emerging trends in the management of immune-related adverse events associated with immune checkpoint inhibitor therapy.免疫检查点抑制剂治疗相关免疫性不良事件管理的最新进展与新趋势
Asia Pac J Oncol Nurs. 2024 Jul 4;11(9):100549. doi: 10.1016/j.apjon.2024.100549. eCollection 2024 Sep.
3
Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers.

本文引用的文献

1
Cancer immunotherapy-associated hypophysitis.癌症免疫治疗相关垂体炎。
Semin Oncol. 2018 Jun;45(3):181-186. doi: 10.1053/j.seminoncol.2018.09.002. Epub 2018 Oct 21.
2
The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors.免疫检查点抑制在脑肿瘤治疗中的作用。
Neurotherapeutics. 2017 Oct;14(4):1049-1065. doi: 10.1007/s13311-017-0513-3.
3
Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma.BRAF野生型晚期黑色素瘤中免疫检查点抑制的成本效益
揭示乳腺癌和肺癌配对脑转移中分子机制并鉴定可药物治疗靶点。
Front Immunol. 2023 Dec 12;14:1305644. doi: 10.3389/fimmu.2023.1305644. eCollection 2023.
4
Advances in NK cell therapy for brain tumors.脑肿瘤自然杀伤细胞疗法的进展。
NPJ Precis Oncol. 2023 Feb 15;7(1):17. doi: 10.1038/s41698-023-00356-1.
5
Tumour invasion and dissemination.肿瘤侵袭与转移。
Biochem Soc Trans. 2022 Jun 30;50(3):1245-1257. doi: 10.1042/BST20220452.
6
Impact of Histotripsy on Development of Intrahepatic Metastases in a Rodent Liver Tumor Model.组织粉碎术对啮齿动物肝肿瘤模型肝内转移瘤发展的影响
Cancers (Basel). 2022 Mar 22;14(7):1612. doi: 10.3390/cancers14071612.
7
Development and characterization of functional antibodies targeting NMDA receptors.靶向 NMDA 受体的功能性抗体的开发和特性鉴定。
Nat Commun. 2022 Feb 17;13(1):923. doi: 10.1038/s41467-022-28559-3.
8
Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications.拓展传统抗体疗法：免疫疗法与临床应用中的新发现。
Mol Ther Oncolytics. 2021 Aug 19;22:166-179. doi: 10.1016/j.omto.2021.08.005. eCollection 2021 Sep 24.
9
Emerging principles of brain immunology and immune checkpoint blockade in brain metastases.脑转移瘤中的脑免疫学和免疫检查点阻断的新兴原则。
Brain. 2021 May 7;144(4):1046-1066. doi: 10.1093/brain/awab012.
10
The future of microfluidics in immune checkpoint blockade.微流控技术在免疫检查点阻断中的未来。
Cancer Gene Ther. 2021 Sep;28(9):895-910. doi: 10.1038/s41417-020-00248-7. Epub 2020 Oct 27.
J Clin Oncol. 2017 Apr 10;35(11):1194-1202. doi: 10.1200/JCO.2016.69.6336. Epub 2017 Feb 21.
4
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review.免疫检查点抑制剂相关不良反应的治疗：综述。
JAMA Oncol. 2016 Oct 1;2(10):1346-1353. doi: 10.1001/jamaoncol.2016.1051.
5
Antagonists of PD-1 and PD-L1 in Cancer Treatment.癌症治疗中PD-1和PD-L1的拮抗剂。
Semin Oncol. 2015 Aug;42(4):587-600. doi: 10.1053/j.seminoncol.2015.05.013. Epub 2015 Jun 10.
6
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.胶质母细胞瘤中程序性死亡配体1的表达与肿瘤浸润淋巴细胞
Neuro Oncol. 2015 Aug;17(8):1064-75. doi: 10.1093/neuonc/nou307. Epub 2014 Oct 29.
7
Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model.在小鼠胶质瘤模型中，局部放射治疗联合4-1BB激活和CTLA-4阻断可产生长期生存及保护性抗原特异性记忆反应。
PLoS One. 2014 Jul 11;9(7):e101764. doi: 10.1371/journal.pone.0101764. eCollection 2014.
8
Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell-mediated glioma rejection.瘤内 IL-12 联合 CTLA-4 阻断引发 T 细胞介导的胶质细胞瘤排斥。
J Exp Med. 2013 Dec 16;210(13):2803-11. doi: 10.1084/jem.20130678. Epub 2013 Nov 25.
9
Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages.胶质瘤通过诱导肿瘤相关巨噬细胞表达 B7-H1 促进免疫抑制。
Clin Cancer Res. 2013 Jun 15;19(12):3165-75. doi: 10.1158/1078-0432.CCR-12-3314. Epub 2013 Apr 23.
10
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.抗 PD-1 抗体在癌症中的安全性、活性和免疫相关性。
N Engl J Med. 2012 Jun 28;366(26):2443-54. doi: 10.1056/NEJMoa1200690. Epub 2012 Jun 2.